Hepatitis B (HBV) vaccines

Fidelia Bernice, Pharm.D., BCIDP, Janessa M. Smith, PharmD, BCPS
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
Hepatitis B (HBV) vaccines is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

VACCINE TYPE

  • Hepilsav-B: yeast-derived vaccine created with a novel adjuvant Toll-like receptor 9 (TLR9) agonist adjuvant
  • Recombivax HB: recombinant vaccine produced by Saccharomyces cerevisiae (baker’s yeast).
  • Engerix-B: recombinant vaccine, also produced by Saccharomyces cerevisiae.
  • Twinrix: bivalent vaccine providing protection against both hepatitis A and B: HAV (720 ELISA units/mL) and HBV (20mcg HBsAg/mL).
  • Comvax: bivalent vaccine providing protection against both Haemophilus influenzae type b and hepatitis B virus (no longer available in the U.S.)

-- To view the remaining sections of this topic, please or --

VACCINE TYPE

  • Hepilsav-B: yeast-derived vaccine created with a novel adjuvant Toll-like receptor 9 (TLR9) agonist adjuvant
  • Recombivax HB: recombinant vaccine produced by Saccharomyces cerevisiae (baker’s yeast).
  • Engerix-B: recombinant vaccine, also produced by Saccharomyces cerevisiae.
  • Twinrix: bivalent vaccine providing protection against both hepatitis A and B: HAV (720 ELISA units/mL) and HBV (20mcg HBsAg/mL).
  • Comvax: bivalent vaccine providing protection against both Haemophilus influenzae type b and hepatitis B virus (no longer available in the U.S.)

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: October 3, 2020